Saturday, March 3, 2012

Investigators from St. Jude Children's Research Hospital Target Stem Cell Research.

According to the authors of recent research published in the journal Clinical Immunology, "FOXP3 is critical for the development and function of CD4(+)CD25(bright) natural regulatory T cells (nTreg). Individuals harboring mutations in FOXP3 develop immune dysregulation, polyendocrinopathy, enteropathy,. X-linked syndrome (IPEX)."

"We describe a child diagnosed with IPEX who underwent a reduced intensity, T and B cell depleted, matched unrelated donor bone marrow transplant followed by clinical resolution. Using lineage-specific donor chimerism studies, we demonstrate that non-myeloablative HSCT resolves disease in the context of low level donor hematopoietic stem cell (HSC) …

No comments:

Post a Comment